Latest Breaking News On - Company to host - Page 1 : comparemela.com

Minerals Technologies Reports First Quarter 2023 Earnings of $1 14 Per Share

Highlights: Record First Quarter Sales of $546 Million, 5 Percent Above Prior YearOperating Income of $63 Million, Increased 43 Percent SequentiallyCash Flow from Operations Improved by $33 Million. | April 27, 2023

United statesDouglast dietrichLydia kopylovaJennifer albertExchange commissionMinerals technologies incImpact of foreign exchangeCompany to hostMinerals technologiesSolutions segmentYork stock exchangeNew york stock exchangeGlobenewswire incFirst quarter salesAbove priorOperations improved

FLEETCOR Technologies, Inc : FLEETCOR Completes Acquisition and Investment in European EV Assets

Company to Host an EV Update Call on Sept. 14, 2022 FLEETCOR Technologies, Inc. (NYSE: FLT), a leading global business payments company, announced today the acquisition of Plugsurfing, a leading

United statesUnited kingdomJim eglsederAsia pacificAlan kingRon clarkeTechnologies incCompany to hostNorth americaLatin america

Pieris Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update

Pieris Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.

United statesStephens yoderMaria kelmanPieris pharmaceuticalsCompany quarterly reports on formBoston pharmaceuticalsExchange commissionCompany annual report on formSecurities exchangePieris pharmaceuticals incCompany to hostInvestor conference call on wednesdayChief executive officerAstrazeneca collaborationServier collaborationQuarter financial update

Pieris Pharmaceuticals, Inc : Pieris Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update

Company To Host an Investor Conference Call On Wednesday, May 11, 2022 At 8:00 Am EDTBOSTON, MA / ACCESSWIRE / May 11, 2022 / Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology

United statesStephens yoderMaria kelmanPieris pharmaceuticalsBoston pharmaceuticalsCompany quarterly reports on formExchange commissionCompany annual report on formSecurities exchangePieris pharmaceuticals incCompany to hostInvestor conference call on wednesdayChief executive officerAstrazeneca collaborationServier collaborationQuarter financial update

Pieris Pharmaceuticals, Inc : Pieris Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update

Company To Host an Investor Conference Call on Tuesday, November 2, 2021 at 8:00 AM EDTDosing completed in part 1a of phase 2a study of PRS-060/AZD1402Dosing to begin this quarter in phase 2 study of cinrebafusp

United statesStephens yoderMaria kelmanAhmed mousaThomas buresEuropean respiratory society international congressDrug administrationPieris pharmaceuticalsCompany quarterly reports on formExchange commissionCompany annual report on formSecurities exchangePieris pharmaceuticals incCompany to hostInvestor conference callChief executive officer